| Name | Title | Contact Details |
|---|
Johnson & Johnson Health Care Systems Inc. (JJHCS) provides contracting, supply chain, business services, and strategic solutions to customers and commercial intermediaries of U.S.-based Johnson & Johnson (J&J) companies, including hospital systems, health plans, distributors, wholesalers, purchasing organizations, government payer programs, and government healthcare institutions in the U.S. JJHCS also engages with customers to provide streamlined supply chain services for our products that seamlessly integrate with customer operations, address shared evolving market challenges to value-based care, and develop innovative solutions that improve patient care and access.
Bodyworks Central is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Valley Health System is a regional healthcare system that serves residents in northern New Jersey and southern New York. It comprises The Valley Hospital, Valley Home Care and Valley Medical Group. Key services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics and neurosciences. Valley Health System’s Centers of Excellence offer comprehensive coordinated inpatient and outpatient programs and services to help ensure excellent clinical outcomes and quality. The Centers of Excellence include Cardiac/Heart Failure, Diabetes, Oncology, Pulmonary, Geriatrics, Total Joint and Neurovascular. Valley maintains affiliations and collaborations with Mount Sinai Health System and with Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute.
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.
BioAbility is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.